NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib
A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Source
- OJEU
- Type
- Framework (Supply)
- Duration
- 10.5 month (est.)
- Value
- £35M
- Sector
- HEALTH
- Published
- 09 Mar 2021
- Delivery
- 21 Dec 2020 to 31 Oct 2021 (est.)
- Deadline
- n/a
Concepts
Location
Runcorn
2 buyers
10 suppliers
- Accord Barnstaple
- Thornton & Ross Huddersfield
- Zentiva Pharma London
- Astrazeneca Luton
- Cipla Eu Addlestone
- Drreddys Laboratories Beverley
- Janssen Cilag High Wycombe
- Sandoz Camberley
- Teva Castleford
- Novartis Pharmaceuticals London
Description
Project title: invitation to offer for NHS National Pharmaceuticals – Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627 Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.
Award Detail
| 1 | Accord (Barnstaple)
|
| 2 | Thornton & Ross (Huddersfield)
|
| 3 | Zentiva Pharma (London)
|
| 4 | Astrazeneca (Luton)
|
| 5 | Cipla Eu (Addlestone)
|
| 6 | Drreddys Laboratories (Beverley)
|
| 7 | Janssen Cilag (High Wycombe)
|
| 8 | Sandoz (Camberley)
|
| 9 | Teva (Castleford)
|
| 10 | Novartis Pharmaceuticals (London)
|
Renewal Options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement.
Award Criteria
| PRICE | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
- Award on basis of price.
Legal Justification
This requirement to call for competition came about due to the availability of competitive supply in circumstances relating to intellectual property rights that could not have been foreseen and/or acted upon by the authority using regular tender timescales.
Other Information
Price is not the only award criterion and all criteria are stated in the procurement documents.
Reference
- OJEU 119375-2021